News | Patient Engagement

Michigan hospitals participating in the American College of Cardiology’s “See You in 7” program demonstrated important reductions in 30-day readmission rates for Medicare heart failure patients compared to non-participating hospitals.

Home September 15, 2015
Home
News | Heart Valve Technology

coramaze technologies GmbH, a German medical device company, announced the closing of a EUR 4.5 million (US$ 5.15 million) series A financing round for the mitramaze valve repair system. The device is a novel concept for transcatheter mitral valve repair (TMVR) intended for treatment of inoperable patients suffering from severe functional mitral regurgitation (fMR).

Home September 15, 2015
Home
News

The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first facility in the United States to use the EpiAccess system to access the pericardial cavity of the heart during an epicardial ablation.

Home September 15, 2015
Home
Technology | Implantable Cardioverter Defibrillator (ICD)

Medtronic received the first U.S. Food and Drug Administration (FDA) approval for an implantable cardioverter defibrillator (ICD) system for use with magnetic resonance imaging (MRI) scans. The Medtronic Evera MRI SureScan ICD System is approved for MRI scans on any part of the body without positioning restrictions, which means that patients who depend on life-saving ICDs also now have access to MRI scans if and when they need them. The newly approved system, which will be commercially available in September 2015, includes the Evera MRI ICD and Sprint Quattro Secure MRI SureScan DF4 leads, which must be used together to be considered MR-conditional.

Home September 14, 2015
Home
Texas Heart Institute, Rice University, grant, nanotubes, heart, electrical signals
Feature | EP Lab

Texas Heart Institute (THI) announced that it has received a prestigious American Heart Association grant alongside Rice University. The three-year, $750,000 grant will allow THI and Rice researchers to study and test soft, flexible fibers made of carbon nanotubes. The fibers’ ability to bridge electrical gaps in tissue is a groundbreaking discovery and offers hope to the millions of people affected by cardiac arrhythmias.

Home September 14, 2015
Home
News | Heart Valve Technology

Startup cardiovascular device manufacturer Valtech Cardio Ltd. announced it has received CE Marking for its Cardioband mitral reconstruction system (Cardioband), a proprietary, implantable mitral reconstruction device with a transfemoral, transseptal delivery system for mitral valve repair.

Home September 14, 2015
Home
Technology | Analytics Software

Vital Images Inc. recently introduced the VioSuite Image Management and Vitality Solutions Business Intelligence product families, providing healthcare administrators with a robust set of tools to improve system-wide image access and image data analytics. VioSuite and Vitality Solutions, as well as the company’s flagship products VitreaAdvanced and VitreaView software, were showcased at the 9th annual Health Information and Management Systems Society (HIMSS) Asia Pacific Conference and Exhibition.

Home September 14, 2015
Home
News | Sudden Cardiac Arrest

September 14, 2015 — Healthcare providers can assess a patient’s risk of sudden cardiac death (SCD) following a ...

Home September 14, 2015
Home
Technology | Antiplatelet and Anticoagulation Therapies

New Haven Pharmaceuticals Inc. announced U.S. Food and Drug Administration (FDA) approval of Durlaza (aspirin) 24-hour extended-release capsules for the secondary prevention of stroke and acute cardiac events, including myocardial infarction.

Home September 11, 2015
Home
News | Radiopharmaceuticals and Tracers

Zevacor Molecular (Zevacor), manufacturer and distributor of positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiopharmaceuticals, announced the arrival of a 70 MeV Cyclotron at its new production facility in Noblesville, Indiana.

Home September 11, 2015
Home
News | Radiopharmaceuticals and Tracers

Westinghouse Electric Company and NorthStar Medical Radioisotopes announced a memorandum of understanding to explore producing medical radioisotopes from the core of commercial nuclear reactors, and methods of global distribution. The exploration involves generating the most widely used radioisotope in medical diagnostic imaging by treating an isotope of the chemical element molybdenum rather than enriched uranium.

Home September 11, 2015
Home
News | Intravascular Imaging

September, 11, 2015 – Japanese medical vendor Nipro Corp. signed a definitive agreement to acquire Infraredx Inc., maker ...

Home September 11, 2015
Home
McKesson Cardiology, CVIS, cardiovascular information system, cardiac PACS
Feature | Cardiovascular Information Systems (CVIS) | Shawn McKenzie, MPA, president, CEO, and Val Kapitula, Ascendian Healthcare Consulting

The cardiovascular service line, whether existing within the confines of an acute-care environment or outpatient setting ...

Home September 11, 2015
Home
McKesson Cardiology, CVIS, cardiovascular information system, cardiac PACS
Feature | Cardiovascular Information Systems (CVIS) | Dave Fornell

For any cardiology department looking to upgrade or replace its cardiovascular information system (CVIS), the main ...

Home September 11, 2015
Home
The McKesson Cardiology CVIS integrates easily with either the McKesson (Change Healthcare) hemodynamics system or other vendors' systems
Feature | Cardiovascular Information Systems (CVIS) | Dave Fornell

Two key requirements for today’s cardiovascular information systems (CVIS) are solid integrations with both enterprise ...

Home September 11, 2015
Home
Subscribe Now